MedTrace Logo

Early Diagnosis of Oral Cancer by Detecting p16 Hydroxymethylation

NCT02967120 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 265

Last updated 2017-09-25

No results posted yet for this study

Summary

The purpose of this study is to verify the function of p16 hydroxymethylation diagnostic reagents in early diagnosis of oral cancer.

Conditions

  • Oral Epithelial Dysplasia

Interventions

OTHER

no intervention

Sponsors & Collaborators

  • Peking University

    collaborator OTHER

  • Beijing Municipal Administration of Hospitals

    lead OTHER_GOV

Principal Investigators

  • Dajun Deng, MD · Peking University Cancer Hosptial and Institute

Eligibility

Min Age
25 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2018-01-31
Completion
2018-01-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02967120 on ClinicalTrials.gov